BSX
Boston Scientific Corp
43.30$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.3% | +12.2% | +7.9% | +8.6% | +9.3% | -7.7% | +19.9% | +6.7% | +12.3% | +17.6% | +19.9% | |
| – | +4.2% | +7.3% | +4.4% | +5.3% | +15.2% | +12.5% | +2.1% | +12.2% | +8.9% | +19.8% | -4.0% | |
| – | -0.5% | +17.1% | +9.9% | +10.3% | +6.2% | -18.9% | +33.8% | +3.4% | +14.5% | +16.3% | +34.9% | |
| – | +7.2% | +5.0% | +8.4% | +11.6% | +5.5% | -2.6% | +5.3% | +9.9% | +6.9% | +14.2% | +27.1% | |
| – | -1.0% | +7.9% | +6.3% | +8.3% | +10.4% | -3.9% | +15.1% | +3.7% | +10.0% | +20.3% | +15.1% | |
| – | +0.8% | +8.8% | +5.8% | +9.1% | +9.0% | -3.7% | +11.3% | +6.3% | +12.9% | +14.8% | +29.5% | |
| – | -6.5% | +56.5% | +23.4% | +13.9% | -1.4% | -64.9% | +219.8% | -5.1% | +19.6% | +20.8% | +50.7% | |
| – | +11.1% | -2.9% | -1.7% | +17.0% | +90.7% | -8.8% | -25.4% | +33.0% | -41.4% | +42.3% | -9.8% | |
| – | – | – | +427.1% | +52.4% | -51.7% | -111.5% | – | +6.0% | +74.0% | +15.0% | +48.3% | |
| – | – | – | – | -130.1% | – | – | +1,700.0% | +1,130.6% | -11.3% | +10.9% | +13.1% | |
| – | – | – | -70.0% | +1,506.7% | +181.3% | -101.7% | – | -32.9% | +128.2% | +16.4% | +55.7% | |
| – | -16.9% | +240.6% | +63.7% | +28.8% | -14.5% | -31.6% | +66.6% | +8.9% | +26.0% | +14.0% | +29.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.